The presentations of the day are available below. The booklet of the day is available here [PDF - 3 Mo].

Présentation du LabEx PRIMES [PDF - 1 Mo]  Introduction to the LabEx PRIMES and expectations of the day
Françoise Peyrin, CREATIS et
Denis Dauvergne, IPNL
Codirecteurs scientifiques de PRIMES

AXINT: gamma detection systems [PDF - 474 Ko]
Benoit Hautefeuille, AXINT SAS, France

MR Spy – Procédé et dispositif de mesure pour des applications de résonance magnétique [PDF - 469 Ko]
Olivier Beuf, CREATIS, Lyon

The Ultrafast Ultrasound Revolution: Current and future applications [PDF - 20 Mo]
Pascal Dardelin, Supersonic Imagine, France

Dosimétrie patients en curiethérapie HDR et PDR par radioluminescence du GaN  [PDF - 749 Ko]:
Recherche/Brevet INL - Industrialisation Dosilab [PDF - 749 Ko]
Loys Gindraux, DOSILAB, Suisse

La modélisation biomécanique humaine: vers la médecine personnalisée [PDF - 1 Mo]
Philippe Vezin, LBMC, Lyon

IBA, the safest way to compact IMPT
Damien Bertrand, IBA, Belgique

Digital biomarkers in medical imaging [PDF - 1 Mo]
Stéphane Chemouny, Intrasens SA, France

Solutions logicielles et prestations pour le traitement et l'analyse d'images 2D et 3D [PDF - 3 Mo]
Laurent Bernard, Reactiv'IP, France

Restauration d'images floues et bruitées [PDF - 1 Mo]
Loïc Denis, LHC, Saint-Etienne

Low energy X-Ray imaging and edge phase contrast enhancement technique
Daniel Brau, Photonic Science, Royaume-Uni

Multi modality imaging for prostate cancer targeting and treatment [PDF - 1 Mo]
Nicolas Guillen, EDAP-TMS, France

Radiobiology modelling for Treatment Planning System in radio/ hadron therapy
Michaël Beuve, IPNL, Lyon

Outils de collaboration et de partenariats académiques – Industriels [PDF - 1 Mo]
Catherine Oudin, Lyon Ingénierie Projets, France

DNA Repair Enzyme Signature as radiotherapy sensitivity biomarker [PDF - 521 Ko]
Sylvie Sauvaigo, LXRepair, France

Activités du pôle de compétitivité Minalogic [PDF - 689 Ko]
Fabien Boulanger, Pôle de compétitivité Minalogic, France

Smart image management - Image streaming [PDF - 850 Ko]
Axel Hars, VOXXL, France

Imagerie proton pour le traitement en protonthérapie [PDF - 11 Mo]
Nicolas Arbor, IPNL/CREATIS, Lyon

Biomechanical and dynamical model of trunk [PDF - 1 Mo]
Jean-Loic Rose, ORTEN, France

TraDeRa, a Transparent Detector for Radiotherapy: a detector for online beam monitoring [PDF - 3 Mo]
Yannick Arnoud, LPSC, Grenoble

VOXCAN: Etudes précliniques et Imagerie Médicale [PDF - 2 Mo]
Emmanuel Chereul, VOXCAN, France

Partenariat avec Dosilab pour l'installation et l'utilisation d'une source gamma [PDF - 457 Ko]
Denis Dauvergne, IPNL, Lyon

The actors of PRIMES have already developed industrial relationships within the Rhône-Alpes–Auvergne region, as attested by a large number of CIFRE PhD*  grants and support letters from a number of companies. It is expected that the visibility of the LabEx research will increase this interaction, especially since this research is associated to sharp technological developments.

PRIMES is already connected to the economic world through tight links with the following structures:

• The Neurodis Foundation

A nationally funded Research and Patient Care Network (RTRS), the Neurodis Foundation was formed in 2007 with a mission to ensure the rapid translation of neuroscience results into clinical applications to benefit patients. It brings together the regional research and patient care resources of the Universities and University Hospitals of Lyon, Grenoble, St Étienne and Clermont-Ferrand. The Foundation’s aims are shared by its partners from the private sector including Merck Serono, the APICIL foundation, KBL Richelieu, CIC – Lyonnaise de Banque, and ADERLY, the Lyon Area Economic Development Agency. PRIMES is well aligned with Neurodis’ aims and will, through reinforcement of human resources, contribute to its success.

• The CLARA Canceropole

The mission of CLARA (Cancéropôle Lyon Auvergne Rhône-Alpes) is to federate research on cancer. Based in the regions of Auvergne and Rhône-Alpes, it establishes strong links between academics, companies and clinicians. Its action results in the implementation of targeted research programmes involving all players concerned by the fight against cancer for better efficiency and more rapid transfer of innovation to patients and to the industry, especially through proof-of-concept programmes.

• The Lyon Biopôle (IRT leader)

Lyon Biopôle is a world competitive cluster accredited in 2005, which already has ongoing collabo­rative projects with PRIMES partners (CREATIS). A centre of excellence in vaccines and diagnostics, it is focused on the fight against human and animal infectious diseases and cancers. Today, Lyon Biopôle is made up of 85 members, among which 4 pharmaceutical industries, 67 small and medium companies and 14 knowledge and resources centres. As a real interface between private and public research, Lyon Biopôle’s mission is to promote exchanges between its members, facilitate scientific collaborations and partnerships, champion high potential projects for national funding and provide an environment for high quality R&D in its domains of activity.

If you represent a private company and wish to contact a team form the LabEx, please do not hesitate to send an e-mail to b.rayet [at] ipnl.in2p3.fr